These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. NAD(P)H:quinone oxidoreductase 1 null genotype is not associated with pediatric de novo acute leukemia. Sirma S; Agaoglu L; Yildiz I; Cayli D; Horgusluoglu E; Anak S; Yuksel L; Unuvar A; Celkan T; Apak H; Karakas Z; Devecioglu O; Ozbek U Pediatr Blood Cancer; 2004 Oct; 43(5):568-70. PubMed ID: 15382274 [TBL] [Abstract][Full Text] [Related]
5. PON1 polymorphisms are predictors of ability to attain HDL-C goals in statin-treated patients. de Souza JA; Menin A; Lima LO; Smiderle L; Hutz MH; Van Der Sand CR; Van Der Sand LC; Ferreira ME; Pires RC; Almeida S; Fiegenbaum M Clin Biochem; 2015 Nov; 48(16-17):1039-44. PubMed ID: 26079344 [TBL] [Abstract][Full Text] [Related]
6. The association of paraoxonase I gene polymorphisms Q192R (rs662) and L55M (rs854560) and its activity with metabolic syndrome components in fars ethnic group. Marjani A; Poursharifi N; Hashemi MM; Sajedi A; Tatari M Horm Mol Biol Clin Investig; 2023 Sep; 44(3):295-303. PubMed ID: 36793191 [TBL] [Abstract][Full Text] [Related]
7. Low NAD(P)H:quinone oxidoreductase activity is associated with increased risk of leukemia with MLL translocations in infants and children. Smith MT; Wang Y; Skibola CF; Slater DJ; Lo Nigro L; Nowell PC; Lange BJ; Felix CA Blood; 2002 Dec; 100(13):4590-3. PubMed ID: 12393620 [TBL] [Abstract][Full Text] [Related]
8. Oxidative stress-related genetic polymorphisms are associated with the prognosis of metastatic gastric cancer patients treated with epirubicin, oxaliplatin and 5-fluorouracil combination chemotherapy. Geng R; Chen Z; Zhao X; Qiu L; Liu X; Liu R; Guo W; He G; Li J; Zhu X PLoS One; 2014; 9(12):e116027. PubMed ID: 25545243 [TBL] [Abstract][Full Text] [Related]
9. Association between rs662 (A > G) and rs854560 (A > T) polymorphisms in PON1 gene and the susceptibility for psoriasis in mestizo population of Western Mexico. Hernández-Collazo AA; Pérez-Méndez O; López-Olmos V; Delgado-Rizo V; Muñoz-Valle JF; Martínez-López E; Villanueva-Quintero DG; Domínguez-Díaz C; Fafutis-Morris M; Alvarado-Navarro A Mol Biol Rep; 2021 Jan; 48(1):183-194. PubMed ID: 33284416 [TBL] [Abstract][Full Text] [Related]
10. Paraoxonase (PON1) polymorphisms Q192R and L55M are not associated with human longevity: A meta-analysis. Wei GZ; Zhu MY; Wang F; Zhao YG; Li SS; Liu TY; Luo Y; Tang WR Z Gerontol Geriatr; 2016 Jan; 49(1):24-31. PubMed ID: 25962362 [TBL] [Abstract][Full Text] [Related]
11. The effect of Çınar E; Akgöllü E; Yücebilgiç G; Bilgin R; Paydaş S Nucleosides Nucleotides Nucleic Acids; 2022; 41(5-6):489-502. PubMed ID: 35306973 [TBL] [Abstract][Full Text] [Related]
12. Paraoxonase 1 genetic polymorphisms and susceptibility to breast cancer: a meta-analysis. Saadat M Cancer Epidemiol; 2012 Apr; 36(2):e101-3. PubMed ID: 22133529 [TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphism of NAD(P)H:quinone oxidoreductase is associated with an increased risk of infant acute lymphoblastic leukemia without MLL gene rearrangements. Lanciotti M; Dufour C; Corral L; Di Michele P; Pigullo S; De Rossi G; Basso G; Leszl A; Luciani M; Lo Nigro L; Micalizzi C; Valsecchi MG; Biondi A; Haupt R Leukemia; 2005 Feb; 19(2):214-6. PubMed ID: 15618957 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of GSTT1, GSTM1 and NQO1 (609C>T) in Filipino children with ALL (acute lymphoblastic leukaemia). Rimando MG; Chua MN; Yuson Ed; de Castro-Bernas G; Okamoto T Biosci Rep; 2008 Jun; 28(3):117-24. PubMed ID: 18444911 [TBL] [Abstract][Full Text] [Related]
15. The Paraoxonase 1 Gene c.-108C>T SNP in the Promoter Is Associated with Risk for Glioma in Mexican Patients, but Not the p.L55M or p.Q192R Polymorphisms in the Coding Region. González-Herrera L; Gamas-Trujillo PA; Medina-Escobedo G; Oaxaca-Castillo D; Pérez-Mendoza G; Williams-Jacquez D; Canto-Cetina T; Vargas-García RD Genet Test Mol Biomarkers; 2015 Sep; 19(9):494-9. PubMed ID: 26154629 [TBL] [Abstract][Full Text] [Related]
16. Human paraoxonase gene polymorphisms and coronary artery disease risk. Mendonça MI; Dos Reis RP; Freitas AI; Sousa AC; Pereira A; Faria P; Gomes S; Silva B; Santos N; Serrão M; Ornelas I; Freitas S; Araújo JJ; Brehm A; Cardoso AA Rev Port Cardiol; 2008 Dec; 27(12):1539-55. PubMed ID: 19280995 [TBL] [Abstract][Full Text] [Related]
17. No association between genetic polymorphisms in NAD(P)H oxidase p22phox and paraoxonase 1 and colorectal cancer risk. Van Der Logt EM; Janssen CH; Van Hooijdonk Z; Roelofs HM; Wobbes T; Nagengast FM; Peters WH Anticancer Res; 2005; 25(2B):1465-70. PubMed ID: 15865106 [TBL] [Abstract][Full Text] [Related]
18. Lack of an association between Paraoxonase 1 gene polymorphisms (Q192R, L55M) and Alzheimer's disease: a meta-analysis. Pi Y; Zhang L; Chang K; Li B; Guo L; Fang C; Gao C; Wang J; Xiang J; Li J Neurosci Lett; 2012 Aug; 523(2):174-9. PubMed ID: 22776645 [TBL] [Abstract][Full Text] [Related]
19. Association of L55M and Q192R polymorphisms of paraoxonase-1 gene with preeclampsia. Yaghmaei M; Hashemi M; Azarian A; Moazeni-Roodi A; Mokhtari M; Naghavai A; Salimi S; Mohammadi M; Taheri M; Ghavami S Arch Med Res; 2011 May; 42(4):324-8. PubMed ID: 21820612 [TBL] [Abstract][Full Text] [Related]
20. PON1 activity and genotype in patients with arterial ischemic stroke and in healthy individuals. Schiavon R; Turazzini M; De Fanti E; Battaglia P; Targa L; Del Colle R; Fasolin A; Silvestri M; Biasioli S; Guidi G Acta Neurol Scand; 2007 Jul; 116(1):26-30. PubMed ID: 17587252 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]